Kalytera Therapeutics Inc.

Company Listings from SPi: Kalytera Therapeutics Inc.

You are here: Home >> SPi Company Listings >> Kalytera Therapeutics Inc.

 

Kalytera Therapeutics Inc.

Website:
http://

Search for other references to "kalytera" on SPi News

Latest Kalytera Therapeutics Inc. News

Kalytera Announces Closing of First Tranche of Private Placement of Common Shares and Common Share Purchase Warrants SAN FRANCISCO and TEL AVIV, Israel, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the “” or “”) is pleased to annou...... 18:06 GMT Monday 16th September 2019

Kalytera Announces Update to Private Placement SAN FRANCISCO and TEL AVIV, Israel, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "" or "") today announced that it is u...... 15:50 GMT Wednesday 11th September 2019

Kalytera Announces Interest Payment in Shares SAN FRANCISCO and TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "" or "") today announced that it has...... 02:48 GMT Tuesday 10th September 2019

Kalytera Reports Second Quarter 2019 Financial Results SAN FRANCISCO and TEL AVIV, Israel, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "" or "") today reported financial resu...... 04:25 GMT Friday 30th August 2019

Kalytera Announces Management-Led Private Placement of Up To $1.5 Million of Common Shares and Common Share Purchase Warrants SAN FRANCISCO and TEL AVIV, Israel, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "" or "") today announced that it inten...... 13:30 GMT Wednesday 21st August 2019

Kalytera to Conclude Phase 2 Clinical Study and Initiate Phase 3 Study SAN FRANCISCO and TEL AVIV, Israel, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "" or "") today announced that interim...... 13:00 GMT Monday 19th August 2019

Kalytera Announces Results of Shareholder Meeting Votes SAN FRANCISCO and TEL AVIV, Israel, July 29, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “” or “”) announced today that...... 19:52 GMT Monday 29th July 2019

Kalytera Will Not Proceed with Vote on Potential Share Consolidation SAN FRANCISCO and TEL AVIV, Israel, July 26, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “” or “”) announced today that...... 23:01 GMT Friday 26th July 2019

Kalytera Announces Completion of Food Effect and QTc Study SAN FRANCISCO and TEL AVIV, Israel, July 16, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "" or "") today announced that it has c...... 13:30 GMT Tuesday 16th July 2019

Kalytera to Acquire CBD Extraction Business SAN FRANCISCO and TEL AVIV, Israel, June 27, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “” or “”) announced today that...... 13:30 GMT Thursday 27th June 2019

Buy Kalytera Therapeutics Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us